Diabetes Drugs and Cardioprotection: 8 Questions on Key Trials

Excess Intake of Ultraprocessed Foods Tied to Higher Cardiometabolic Risk: Daily Dose

News

Slideshow

Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.

Related Content

August 22nd 2025

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Your daily dose of the clinical news you may have missed.

July 8th 2025

Use of Digital Twin Technology Enabled Significant HbA1c Reduction and Medication Tapering in Primary Care T2D Management

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Digital twin technology enables HbA1c reduction and medication tapering in primary care T2D management / image credit courtesy of Cleveland Clinic Kevin Pantalone, DO

August 21st 2025

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

A Cleveland Clinic trial revealed that AI-driven precision treatment significantly reduced HbA1c and body weight, often eliminating need for medications other than metformin.

August 30th 2023

AHA/ACC Release Revised Hypertension Clinical Practice Guideline to Reduce CVD Risk

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Guideline Topline: 2025 AHA/ACC Hypertension / image credit Dan Jones, MD, University of Mississippi Foundation

GLP-1 RAs Prescribed for More Than One-Third of US Adults With Diabetes in Middle Age: NCHS Data Brief

Updates to the 2017 guideline focus on new monitoring strategies, earlier intervention to reduce cognitive decline, improved perinatal care, and refined risk assessment.

GLP-1 RAs Prescribed for More Than One-Third of US Adults With Diabetes in Middle Age: NHIS Data Brief / image credit ©Sebastian Garcia/stock.adobe.com

Excess Intake of Ultraprocessed Foods Tied to Higher Cardiometabolic Risk: Daily Dose

GLP-1 use among adults with diabetes peaked among those aged 50 to 64 years, was highest among Hispanic adults, and was more likely among those taking other antihyperglycemic agents.

Related Content

August 22nd 2025

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Your daily dose of the clinical news you may have missed.

July 8th 2025

Use of Digital Twin Technology Enabled Significant HbA1c Reduction and Medication Tapering in Primary Care T2D Management

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

August 21st 2025

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

A Cleveland Clinic trial revealed that AI-driven precision treatment significantly reduced HbA1c and body weight, often eliminating need for medications other than metformin.

August 30th 2023

AHA/ACC Release Revised Hypertension Clinical Practice Guideline to Reduce CVD Risk

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

GLP-1 RAs Prescribed for More Than One-Third of US Adults With Diabetes in Middle Age: NCHS Data Brief

Updates to the 2017 guideline focus on new monitoring strategies, earlier intervention to reduce cognitive decline, improved perinatal care, and refined risk assessment.